| Unique ID issued by UMIN | UMIN000061813 |
|---|---|
| Receipt number | R000070732 |
| Scientific Title | A Multicenter Prospective Study on the Clinical Implementation of Rapid Genomic Diagnosis and the Development of a Family Support Program for Neonates with Differences of Sex Development and Uncertain Legal Sex Assignment |
| Date of disclosure of the study information | 2026/07/01 |
| Last modified on | 2026/06/05 23:21:55 |
A Multicenter Prospective Study on the Clinical Implementation of Rapid Genomic Diagnosis and the Development of a Family Support Program for Neonates with Differences of Sex Development and Uncertain Legal Sex Assignment
Bridging Rapid Investigation, Diagnosis, Genomics, and Engagement for DSD (BRIDGE-DSD)
A Multicenter Prospective Study on the Clinical Implementation of Rapid Genomic Diagnosis and the Development of a Family Support Program for Neonates with Differences of Sex Development and Uncertain Legal Sex Assignment
Bridging Rapid Investigation, Diagnosis, Genomics, and Engagement for DSD (BRIDGE-DSD)
| Japan |
Differences of Sex Development
| Endocrinology and Metabolism | Pediatrics |
Others
YES
This multicenter, prospective observational (registry) study evaluates the clinical feasibility of rapid genomic diagnosis and the usefulness of a multidisciplinary family-support program for newborns with differences of sex development (DSD) in whom legal sex assignment is difficult. It also assesses the effectiveness of shared decision-making support for sex assignment, longitudinal changes in parental psychological status and family quality of life, and differences in outcomes according to the availability of multidisciplinary care, while establishing a nationwide registry of neonatal DSD.
Others
bservational study and registry to evaluate the feasibility of implementing rapid genomic diagnosis and to assess the usefulness of a family-support program.
Others
Not applicable
Diagnostic yield: the proportion of patients in whom rapid genomic testing identifies a pathogenic (P) or likely pathogenic (LP) variant and establishes a molecular genetic diagnosis, assessed during the study observation period.
1. Time to diagnosis: days from the first visit to the date the analysis result is reported to each site, and the corresponding age in days.
2. Time to legal sex assignment: days from the first visit to the date the sex field of the birth registration is submitted, and the corresponding age in days.
3. Distribution of DSD etiologies and distribution of the External Genitalia Score (EGS).
4. Proportion of cases with correction of the legally assigned sex at 1 and 5 years of age.
5. Quality of shared decision-making (SDM-Q-9).
6. Parental scores and longitudinal changes in psychological distress (K10), traumatic stress (IES-R), decision regret (DRS), perceived uncertainty (PPUS), and the concept of gender (HABS, GDS, GES, etc.).
7. Exploratory between-group comparison of the multidisciplinary-team sites and the collaborating sites.
Observational
| Not applicable |
| 14 | days-old | >= |
Male and Female
1. Newborns with DSD under 14 days of age in whom the attending physician has deferred legal sex assignment, with an External Genitalia Score (EGS) of >=0.5 that is below the 10th percentile for boys by gestational age (10.5 at >=33 weeks, 9.0 at 28-32 weeks, 8.5 at <28 weeks).
2. Patients who began care at a participating site of this study.
3. Patients for whom written consent has been obtained from a parent (legally authorized representative).
1. Patients with a prenatally identified numerical sex-chromosome abnormality or similar finding.
2. Patients with a high likelihood of congenital adrenal hyperplasia, such as those with skin hyperpigmentation.
3. Patients judged to have a poor life prognosis due to serious comorbidities.
4. Any other patient judged unsuitable by the principal investigator.
50
| 1st name | Tomohiro |
| Middle name | |
| Last name | Ishii |
Tokyo Metropolitan Children's Medical Center
Department of Endocrinology and Metabolism
183-8561
2-8-29 Musashidai, Fuchu, Tokyo 183-8561, Japan
042-300-5111
tomishii@keio.jp
| 1st name | Tomohiro |
| Middle name | |
| Last name | Ishii |
Tokyo Metropolitan Children's Medical Center
Department of Endocrinology and Metabolism (Study Office)
183-8561
2-8-29 Musashidai, Fuchu, Tokyo 183-8561, Japan
042-300-5111
tomishii@keio.jp
Tokyo Metropolitan Children's Medical Center
Tomohiro Ishii
Japan Agency for Medical Research and Development (AMED)
Japanese Governmental office
Japan
"Central Research Ethics Committee of Tokyo Metropolitan Organization
2-8-29 Musashidai, Fuchu, Tokyo 183-8561, Japan
042-300-5111
tmerp_erb@tmhp.jp
NO
東京都立小児総合医療センター(東京都)、倉敷中央病院(岡山県)、長野県立こども病院(長野県)、大阪市立総合医療センター(大阪府)、あいち小児保健医療総合センター(愛知県)、大阪母子医療センター(大阪府)、名古屋市立大学(愛知県)、慶應義塾大学(東京都)、滋賀医科大学(滋賀県)、新潟大学(新潟県)、鹿児島大学(鹿児島県)、兵庫県立こども病院(兵庫県)、成育医療研究センター(東京都)、福岡市立こども病院(福岡県)、岡山大学(岡山県)、東京科学大学(東京都)、宮城県立こども病院(宮城県)、関西医科大学(大阪府)、愛知医科大学(愛知県)、東京大学(東京都)、浜松医科大学(静岡県)、秋田大学(秋田県)、北海道大学(北海道)、国立病院機構甲府病院(山梨県)、長崎大学(長崎県)、国立病院機構小倉医療センター(福岡県)、広島大学(広島県)、旭川医科大学(北海道)、山梨大学(山梨県)、国立病院機構岡山医療センター(岡山県)、岐阜大学(岐阜県)、千葉大学(千葉県)、熊本大学(熊本県)、静岡県立こども病院(静岡県)、弘前大学(青森県)、大分大学(大分県)、東北大学(宮城県)、沖縄県立中部病院(沖縄県)、大阪大学(大阪府)、埼玉医科大学(埼玉県)、奈良県立医科大学(奈良県)、藤田医科大学(愛知県)、東京歯科大学市川総合病院(千葉県)、川崎市立川崎病院(神奈川県)、京都府立医科大学(京都府)、産業医科大学(福岡県)、福岡大学(福岡県)、富山大学(富山県)、新潟市民病院(新潟県)、東京慈恵会医科大学(東京都)、順天堂大学(東京都)、明治大学(東京都)
| 2026 | Year | 07 | Month | 01 | Day |
Unpublished
Preinitiation
| 2026 | Year | 06 | Month | 05 | Day |
| 2026 | Year | 02 | Month | 12 | Day |
| 2026 | Year | 07 | Month | 01 | Day |
| 2035 | Year | 03 | Month | 31 | Day |
Nothing particular
| 2026 | Year | 06 | Month | 05 | Day |
| 2026 | Year | 06 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070732